Valence8 US LP
- SEC CIK
- 0001943819
- Latest filing
- Aug 6, 2026
Holdings in Q3 2024
Holdings as of Sep 30, 2024, filed Nov 12, 2024. Long positions only; changes compare share counts with Q2 2024.
- Positions
- 40
- +31 vs. Q2 2024
- Portfolio value
- $229.4M
- +$37.6M (+19.6%) vs. Q2 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| iShares MSCI USA Quality Factor ETF46432F339 | ETF | 337,472 | $60.5M | 26.4% | +36,424+12.1% | Added | – |
| Invesco QQQ Trust Series I46090E103 | ETF | 88,149 | $43.0M | 18.8% | +11,438+14.9% | Added | – |
| iShares Tr46434V456 | MSCI INTL QUALTY | 1,026,290 | $42.6M | 18.6% | +134,097+15.0% | Added | – |
| iShares Tr464288877 | EAFE VALUE ETF | 399,186 | $23.0M | 10.0% | 00.0% | Unchanged | – |
| Vanguard Morningstar Value ETF922908744 | ETF | 96,630 | $16.9M | 7.4% | −3,373−3.4% | Reduced | – |
| State Street Consumer Staples Select Sector SPDR ETF81369Y308 | ETF | 165,267 | $13.7M | 6.0% | −3,033−1.8% | Reduced | – |
| iShares Tr46435G334 | MSCI UK ETF NEW | 209,344 | $7.83M | 3.4% | −7,590−3.5% | Reduced | – |
| iShares Inc46434G822 | MSCI JAPAN ETF | 108,634 | $7.77M | 3.4% | 00.0% | Unchanged | – |
| State Street Utilities Select Sector SPDR ETF81369Y886 | ETF | 51,940 | $4.20M | 1.8% | −3,648−6.6% | Reduced | – |
| JAZZJazz Pharmaceuticals plc | SHS USD | 8,969 | $999.2K | 0.4% | +8,969 | New | History |
| BMYBristol Myers Squibb Co | Stock | 17,785 | $920.2K | 0.4% | +17,785 | New | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 4,585 | $684.6K | 0.3% | +4,585 | New | History |
| INSMINSMED Inc | COM PAR $.01 | 7,865 | $574.1K | 0.3% | +7,865 | New | History |
| INDVIndivior Pharmaceuticals, Inc. | ORD | 57,293 | $564.2K | 0.2% | +57,293 | New | History |
| LLYEli Lilly & Co | Stock | 633 | $560.8K | 0.2% | +633 | New | History |
| ARGXArgenx SE | SPONSORED ADR | 953 | $516.6K | 0.2% | +953 | New | History |
| SLNOSoleno Therapeutics Inc | COM | 9,706 | $490.1K | 0.2% | +9,706 | New | History |
| KROSKeros Therapeutics, Inc. | COM | 8,025 | $466.0K | 0.2% | +8,025 | New | History |
| NUVLNuvalent, Inc. | COM | 4,115 | $421.0K | 0.2% | +4,115 | New | History |
| JANXJanux Therapeutics, Inc. | COM | 7,857 | $356.9K | 0.2% | +7,857 | New | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 6,684 | $341.6K | 0.1% | +6,684 | New | History |
| TYRATyra Biosciences, Inc. | COM | 13,188 | $310.1K | 0.1% | +13,188 | New | History |
| APGEApogee Therapeutics, Inc. | COM | 5,240 | $307.8K | 0.1% | +5,240 | New | History |
| PCVXVaxcyte, Inc. | COM | 2,468 | $282.0K | 0.1% | +2,468 | New | History |
| NTLAIntellia Therapeutics, Inc. | COM | 13,020 | $267.6K | 0.1% | +13,020 | New | History |
| VIRVir Biotechnology, Inc. | COM | 33,650 | $252.0K | 0.1% | +33,650 | New | History |
| BPMCBlueprint Medicines Corp | COM | 2,618 | $242.2K | 0.1% | +2,618 | New | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 4,241 | $235.6K | 0.1% | +4,241 | New | History |
| ENTAEnanta Pharmaceuticals Inc | COM | 19,939 | $206.6K | 0.1% | +19,939 | New | History |
| RLAYRelay Therapeutics, Inc. | COM | 26,200 | $185.5K | 0.1% | +26,200 | New | History |
| ZVRAZevra Therapeutics, Inc. | COM NEW | 21,596 | $149.9K | 0.1% | +21,596 | New | History |
| ERASErasca, Inc. | COM | 46,923 | $128.1K | 0.1% | +46,923 | New | History |
| SLDBSolid Biosciences Inc. | COM NEW | 15,728 | $109.6K | <0.1% | +15,728 | New | History |
| VTGNVistagen Therapeutics, Inc. | COM | 34,376 | $103.5K | <0.1% | +34,376 | New | History |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 17,495 | $71.0K | <0.1% | +17,495 | New | History |
| ALECAlector, Inc. | COM | 14,708 | $68.5K | <0.1% | +14,708 | New | History |
| CLYMClimb Bio, Inc. | COM | 12,045 | $61.3K | <0.1% | +12,045 | New | History |
| CYPHCypherpunk Technologies Inc. | COM NEW | 18,511 | $47.6K | <0.1% | +18,511 | New | History |
| NKTRNektar Therapeutics | COM | 26,107 | $33.9K | <0.1% | +26,107 | New | History |
| KZRKezar Life Sciences, Inc. | COM | 21,136 | $16.3K | <0.1% | +21,136 | New | History |
Options (20)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| AZNAstraZeneca PLC | SPONSORED ADR | – | $4.99M |
| AMGNAmgen Inc | Stock | $644.4K | $644.4K |
| SLNOSoleno Therapeutics Inc | COM | – | $631.1K |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | – | $615.4K |
| INSMINSMED Inc | COM PAR $.01 | – | $481.8K |
| NVONovo Nordisk A S | ADR | – | $464.4K |
| FLNAFilana Therapeutics, Inc. | COM | $415.0K | – |
| RAREUltragenyx Pharmaceutical Inc. | COM | – | $383.3K |
| APLSApellis Pharmaceuticals, Inc. | COM | – | $377.8K |
| AVDLAvadel Pharmaceuticals PLC | Stock | – | $343.6K |
| ALTAltimmune, Inc. | COM NEW | $144.3K | $160.9K |
| VRDNViridian Therapeutics, Inc. | COM | – | $298.0K |
| MRNAModerna, Inc. | Stock | – | $274.0K |
| CLDXCelldex Therapeutics, Inc. | COM NEW | $220.9K | – |
| APLTApplied Therapeutics, Inc. | COM | – | $172.6K |
| IOVAIovance Biotherapeutics, Inc. | COM | – | $123.0K |
| JANXJanux Therapeutics, Inc. | COM | $104.5K | – |
| BCRXBiocryst Pharmaceuticals Inc | COM | – | $99.6K |
| CCCCC4 Therapeutics, Inc. | COM STK | – | $59.9K |
| GOSSGossamer Bio, Inc. | COM | – | $20.4K |